Pfizer Pharma GmbH

Industry / private company


Location: Berlin, Germany (DE) DE

ISNI: 0000000449048590

ROR: https://ror.org/00m8w3m39

Show on Map:

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Sirolimus in renal transplant recipients with malignancies in Germany (2021) Naik MG, Arns W, Budde K, Diekmann F, Eitner F, Gwinner W, Heyne N, et al. Journal article Assessment of prognosis by established prognosis scores and physicians' judgement in mRCC patients: an analysis of the STAR-TOR registry (2020) Boegemann M, Goebell P, Woike M, Buncke J, Schlack K, Schrader AJ Journal article Prediction of therapy response in acromegalic patients under pegvisomant therapy within the German ACROSTUDY cohort (2015) Sievers C, Baur DM, Schwanke A, Buchfelder M, Droste M, Mann K, Stalla GK Journal article Therapy of acromegalic patients exacerbated by concomitant type 2 diabetes requires higher pegvisomant doses to normalise IGF1 levels (2014) Droste M, Domberg J, Buchfelder M, Mann K, Schwanke A, Stalla G, Strasburger CJ Journal article